Arlenda is recognized as a global leader in the application of Bayesian methodology consulting and programming to the Biopharma industry, from preclinical to late phase studies and in a wide range of therapeutic areas. Beginning in non-clinical studies and continuing through Phase 2, all efforts are made to ensure the success of the Phase 3 study and the eventual approval of the NDA. Modeling the effect of the drug product on the body, including the inherent uncertainty and predicting the effects of changes in dosages, administration, or frequency can have a profound effect on both the cost and duration of a development program. ARLENDA CAN HELP. Visit our website (which is listed below) to learn more about Arlenda's hands-on experience in implementing Bayesian Modeling and Designs using the following software: R, STAN, SAS, Winbugs and NONMEM.
Arlenda is recognized as a global leader in the application of Bayesian methodology consulting and programming to the Biopharma industry, from preclinical to late phase studies and in a wide range of therapeutic areas. Beginning in non-clinical studies and continuing through Phase 2, all efforts are made to ensure the success of the Phase 3 study and the eventual approval of the NDA. Modeling the effect of the drug product on the body, including the inherent uncertainty and predicting the effects of changes in dosages, administration, or frequency can have a profound effect on both the cost and duration of a development program. ARLENDA CAN HELP. Visit our website (which is listed below) to learn more about Arlenda's hands-on experience in implementing Bayesian Modeling and Designs using the following software: R, STAN, SAS, Winbugs and NONMEM.
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Rue Edouard Belin, 5 Mont-Saint-Guibert
- City
- Region
- Brussels
- Postal Code
- Country
- Belgium